Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PharmaEssentia | Taiwan | Healthcare | Biotechnology & Medical Research | NT$232.02B | 124.9x | 0.43 | NT$715 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.2% Upside | Upgrade to Pro+ | |
Bora Pharmas | Taiwan | Healthcare | Pharmaceuticals | NT$86.60B | 21.8x | 0.71 | NT$858 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15% Upside | Upgrade to Pro+ | |
Lotus Pharma | Taiwan | Healthcare | Pharmaceuticals | NT$74.18B | 16.9x | 1.49 | NT$276.50 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.3% Upside | Upgrade to Pro+ | |
Lumosa Therapeutics | TPEX | Healthcare | Biotechnology & Medical Research | NT$42.73B | -105.9x | NT$253 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.1% Downside | Upgrade to Pro+ | ||
Oneness Biotech | TPEX | Healthcare | Pharmaceuticals | NT$36.72B | -29.1x | -1.94 | NT$77.20 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Polaris Group | Taiwan | Healthcare | Biotechnology & Medical Research | NT$36.34B | -16.1x | 0.22 | NT$48.20 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pegavision | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$29.41B | 14.7x | 0.73 | NT$378.50 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.7% Upside | Upgrade to Pro+ | |
Center Laboratories | TPEX | Healthcare | Pharmaceuticals | NT$29.07B | -68.2x | -1.25 | NT$40.35 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
EirGenix | TPEX | Healthcare | Pharmaceuticals | NT$25.33B | -25.7x | 0.44 | NT$83.80 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiMed Biologics | TPEX | Healthcare | Biotechnology & Medical Research | NT$24.55B | -167.1x | -8.63 | NT$89.90 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.4% Upside | Upgrade to Pro+ | |
TTY Biopharm | TPEX | Healthcare | Pharmaceuticals | NT$19B | 17x | -3.85 | NT$76.40 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.1% Upside | Upgrade to Pro+ | |
Universal Vision BioTech | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$18.51B | 17.2x | 4.26 | NT$218.50 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.6% Downside | Upgrade to Pro+ | |
SPT | Taiwan | Healthcare | Pharmaceuticals | NT$17.83B | 44.7x | 0.61 | NT$22.35 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.4% Upside | Upgrade to Pro+ | |
PharmaEngine | TPEX | Healthcare | Biotechnology & Medical Research | NT$17.03B | 45.9x | 1.72 | NT$118.50 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.3% Upside | Upgrade to Pro+ | |
Medigen Vaccine Biologics | TPEX | Healthcare | Pharmaceuticals | NT$15.99B | -25x | -0.52 | NT$47 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OBI Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$15.70B | -6.5x | 0.08 | NT$59.70 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tanvex BioPharma | Taiwan | Healthcare | Biotechnology & Medical Research | NT$15.62B | -6x | -0.28 | NT$67.50 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sunmax BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$14.92B | 21.4x | 1.05 | NT$290.50 | 6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gongwin Biopharm | TPEX | Healthcare | Biotechnology & Medical Research | NT$14.88B | -134.3x | -3.57 | NT$116 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Y.S.H. | Taiwan | Healthcare | Pharmaceuticals | NT$14.73B | 14.3x | 0.31 | NT$55.10 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Synmosa Biopharma | TPEX | Healthcare | Pharmaceuticals | NT$14.18B | 19.7x | 1.15 | NT$33.75 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.7% Upside | Upgrade to Pro+ | |
Excelsior | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$14.12B | 18.4x | 2.49 | NT$86.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.8% Downside | Upgrade to Pro+ | |
CHO Pharma | TPEX | Healthcare | Pharmaceuticals | NT$13.85B | -52.2x | -1.79 | NT$61.90 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taidoc Tech | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$13.50B | 15.2x | -0.49 | NT$141 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6% Upside | Upgrade to Pro+ | |
Foresee Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$12.51B | -11.8x | -1.83 | NT$84.20 | 4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lin Bio | TPEX | Healthcare | Pharmaceuticals | NT$11.36B | -15.3x | 0.48 | NT$144.50 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Handa Pharmas | TPEX | Healthcare | Pharmaceuticals | NT$11B | 24x | -1.1 | NT$81.10 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SCPC | Taiwan | Healthcare | Pharmaceuticals | NT$10.97B | 12.9x | NT$61.10 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.3% Upside | Upgrade to Pro+ | ||
SCI Pharmtech | Taiwan | Healthcare | Pharmaceuticals | NT$10.22B | 20.9x | 1.28 | NT$86.20 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ADIM | Taiwan | Healthcare | Pharmaceuticals | NT$10.18B | -16.8x | 0.07 | NT$23.95 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.8% Downside | Upgrade to Pro+ | |
St.Shine Optical | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$9.50B | 15.1x | 9.47 | NT$188.50 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.8% Upside | Upgrade to Pro+ | |
United Orthopedic | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$9.45B | 20.4x | 1.36 | NT$98 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.6% Upside | Upgrade to Pro+ | |
Mycenax Biotech | TPEX | Healthcare | Biotechnology & Medical Research | NT$9.10B | -16.9x | -0.68 | NT$44.75 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Formosa Lab | Taiwan | Healthcare | Pharmaceuticals | NT$8.92B | 22.7x | 0.5 | NT$73.10 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioteque | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$8.73B | 17.5x | 2.08 | NT$126 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SVBI | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$8.58B | 37.7x | 1.14 | NT$120.50 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28% Upside | Upgrade to Pro+ | |
CHC Healthcare | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$8.56B | 26.3x | 3.69 | NT$50.20 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.5% Downside | Upgrade to Pro+ | |
Orient Pharma | TPEX | Healthcare | Pharmaceuticals | NT$8.39B | 70.4x | 0.21 | NT$38.15 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taigen BioPharmas | TPEX | Healthcare | Pharmaceuticals | NT$8.33B | 48.5x | 0.24 | NT$11.60 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Panion BF Biotech | Taiwan | Healthcare | Pharmaceuticals | NT$7.51B | 61.7x | 0.18 | NT$86 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.2% Upside | Upgrade to Pro+ | |
Easywell Biomedical | TPEX | Healthcare | Pharmaceuticals | NT$7.36B | -59.2x | -3.03 | NT$60.40 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Onyx Healthcare | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$6.74B | 36.9x | -1.18 | NT$169.50 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pacific Hospital Supply | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$6.72B | 16.3x | -1.95 | NT$92.60 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.7% Upside | Upgrade to Pro+ | |
Savior Lifetec | TPEX | Healthcare | Pharmaceuticals | NT$6.65B | 37x | 0.1 | NT$20.95 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hi-Clearance | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$6.43B | 17.4x | 20.37 | NT$144.50 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sinphar | Taiwan | Healthcare | Pharmaceuticals | NT$5.72B | 17.2x | 0.84 | NT$31.15 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.9% Downside | Upgrade to Pro+ | |
Icares Medicus | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$5.49B | 82.7x | -1.56 | NT$130 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intai Tech | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$5.47B | 25.8x | -0.59 | NT$110 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medigen BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$4.91B | -11.9x | -0.4 | NT$35.25 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bionet | TPEX | Healthcare | Biotechnology & Medical Research | NT$4.39B | 77.9x | -2.39 | NT$86.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |